$AMPH

4 stories mentioning AMPHUpdated 41d ago

Every FINWIRES story that references AMPH, newest first.

Update: BofA Securities Downgrades Amphastar Pharmaceuticals to Underperform From Neutral, Cuts Price Target to $20 From $25

(Updates with prior rating and price target as well as analyst averages.)Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AMPH

Wire87d ago

Amphastar Shares Fall After Wells Fargo Downgrade

Amphastar Pharmaceuticals (AMPH) shares were falling over 4% in late Thursday trading after Wells Fargo downgraded the stock to equal-weight from overweight, and cut its price target to $19 from $30.Trading volume stood at more than 448,000 shares, compared with a daily average of about 592,000.Price: $17.43, Change: $-0.89, Percent Change: -4.86%

$AMPH

Research87d ago

Wells Fargo Downgrades Amphastar Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $19 From $30

Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $23.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AMPH

Research110d ago

Jefferies Downgrades Amphastar Pharmaceuticals to Hold From Buy, Adjusts Price Target to $22 From $30

Amphastar Pharmaceuticals (AMPH) has an average rating of overweight and mean price target of $26.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AMPH

Track with the FINWIRES app suite

FolioX

Track AMPH in your portfolio

WheelAI

Analyze AMPH options with the wheel strategy

StockInsider

See market sentiment on AMPH